Copyright
©The Author(s) 2024.
World J Gastroenterol. Sep 28, 2024; 30(36): 4036-4043
Published online Sep 28, 2024. doi: 10.3748/wjg.v30.i36.4036
Published online Sep 28, 2024. doi: 10.3748/wjg.v30.i36.4036
Figure 2 Glucagon-like peptide-1 receptor agonists improve ovarian dysfunction in a mouse model of polycystic ovary syndrome.
GLP-1RA: Glucagon-like peptide-1 receptor agonists; GLP-1: Glucagon-like peptide-1; PCOS: Polycystic ovary syndrome; DFMA: Difluoro methylarginine.
- Citation: Kong MW, Yu Y, Wan Y, Gao Y, Zhang CX. Glucagon-like peptide-1 receptor agonists: Exploring the mechanisms from glycemic control to treatment of multisystemic diseases. World J Gastroenterol 2024; 30(36): 4036-4043
- URL: https://www.wjgnet.com/1007-9327/full/v30/i36/4036.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i36.4036